<?xml version="1.0" encoding="UTF-8"?>
<ref id="B140-vaccines-08-00468">
 <label>140.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Baldassarre</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Di Mauro</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Labellarte</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Pignatelli</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fanelli</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Schiavi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Mastromarino</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Capozza</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Panza</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Laforgia</surname>
    <given-names>N.</given-names>
   </name>
  </person-group>
  <article-title>Resveratrol plus carboxymethyl-Î²-glucan in infants with common cold: A randomized double-blind trial</article-title>
  <source>Heliyon</source>
  <year>2020</year>
  <volume>6</volume>
  <fpage>e03814</fpage>
  <pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e03814</pub-id>
  <pub-id pub-id-type="pmid">32322697</pub-id>
 </element-citation>
</ref>
